We have added a summary of a recent speaker event titled ‘Rethinking the role of pralatrexate in PTCL: how monotherapy can change the natural history of a challenging disease.’
The presentation was given by Professor Owen O’Connor, an international authority in lymphoma and drug development, with more than 25 years of experience in academic medicine.
Please login below to download this issue (PDF)